Safety and efficacy of adjunct tirofiban treatment following mechanical thrombectomy for acute ischemic stroke patients with large vessel occlusion (LVO) resulting in successful reperfusion

Abstract

Background and purpose

Tirofiban administration after mechanical thrombectomy (MT) remains controversial. This study aimed to investigate the efficacy and safety of adjunct tirofiban treatment following MT for acute ischemic stroke (AIS) patients with large vessel occlusion (LVO) that resulted in successful reperfusion on digital subtraction angiography (DSA).

Methods

This retrospective study was conducted in Zhengzhou University University People's Hospital, an advanced stroke center in China. Consecutive patients with AIS who underwent endovascular therapy (EVT) were enrolled from June 2018 to January 2022. The safety endpoints were symptomatic intracerebral hemorrhage (sICH), total intracranial hemorrhage (ICH), and 3-month mortality. The efficacy endpoints were 3-month modified Rankin scale (mRS) score and 24-h neurological improvement.

Results

A total of 145 consecutive patients with AIS who underwent MT were analyzed, of whom 51 (35.2%) patients were in the tirofiban group. There were 30 (20.7%) patients with sICH, 50 (34.5%) patients suffered from ICH within 24-h post-MT, and 47 (32.4%) dead at 3-month. Besides, 31 (21.4%) patients achieved excellent clinical outcomes (mRS, 0-1), and 24-h neurological improvement was found in 29 (20.0%) patients. No statistically significant differences were found in safety outcomes on sICH, total ICH, and 3-month mortality, as well as efficacy outcomes on 3-month mRS scores (0-1) and 24-h neurological improvement between the two groups (P > 0.05 for all). Additionally, tirofiban was associated with 3-month mRS scores of 0-2 (adjusted odds ratio (OR), 3.75; 95% confidence interval (CI), 1.41–10.02, P = 0.008).

Conclusion

Adjunct tirofiban treatment following MT for AIS patients with LVO that resulted in successful reperfusion on DSA was not correlated with the increased risk of safety endpoints on sICH, ICH, and 3-month mortality, and it may be associated with a lower 3-month mRS score.

Keywords

Tirofiban acute ischemic stroke mechanical thrombectomy vessel recanalization

Get full access to this article

View all access options for this article.

References

Berkhemer

Fransen

Beumer

, et al. A randomized trial of intraarterial treatment for acute ischemic stroke [published correction appears in N Engl J Med. 2015 Jan 22;372(4):394]. N Engl J Med 2015; 372: 11–20.

Campbell

Mitchell

Kleinig

, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015; 372: 1009–1018.

Goyal

Demchuk

Menon

, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015; 372: 1019–1030.

Jovin

Chamorro

Cobo

, et al. Thrombectomy within 8 h after symptom onset in ischemic stroke. N Engl J Med 2015; 372: 2296–2306.

Saver

Goyal

Bonafe

, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015; 372: 2285–2295.

Goyal

Menon

van Zwam

, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: A meta-analysis of individual patient data from five randomised trials. Lancet 2016; 387: 1723–1731.

Rabinstein

Albers

Brinjikji

, et al. Factors that may contribute to poor outcome despite good reperfusion after acute endovascular stroke therapy. Int J Stroke 2019; 14: 23–31.

Churilov

Yassi

, et al. Prevalence and significance of impaired microvascular tissue reperfusion despite macrovascular angiographic reperfusion (No-reflow). Neurology 2022; 98: e790–e801.

Xie

Oppenheim

Guillemin

, et al. Pretreatment lesional volume impacts clinical outcome and thrombectomy efficacy. Ann Neurol 2018; 83: 178–185.

10.

Zlokovic

. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008; 57: 178–201.

11.

De Silva

Fink

Christensen

, et al. Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET). Stroke 2009; 40: 2872–2874.

12.

Eilaghi

Brooks

d’Esterre

, et al. Reperfusion is a stronger predictor of good clinical outcome than recanalization in ischemic stroke. Radiology 2013; 269: 240–248.

13.

Schwarz

Meade

Stoll

, et al. Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets. Circ Res 2006; 99: 25–33.

14.

Yang

Huo

Gao

, et al. Low-dose rescue tirofiban in mechanical thrombectomy for acute cerebral large-artery occlusion. Eur J Neurol 2020; 27: 1056–1061.

15.

Pan

Zheng

, et al. Safety and efficacy of tirofiban combined with endovascular treatment in acute ischaemic stroke. Eur J Neurol 2019; 26: 1105–1110.

16.

Huo

Yang

, et al. Safety and efficacy of tirofiban during mechanical thrombectomy for stroke patients with preceding intravenous thrombolysis. Clin Interv Aging 2020; 15: 1241–1248. Published 2020 Jul 23.

17.

Renú

Millán

San Román

, et al. Effect of intra-arterial alteplase vs placebo following successful thrombectomy on functional outcomes in patients with large vessel occlusion acute ischemic stroke: the CHOICE randomized clinical trial. JAMA 2022; 327: 826–835.

18.

Hacke

Kaste

Fieschi

, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998; 352: 1245–1251.

19.

Yemisci

Gursoy-Ozdemir

Vural

, et al. Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat Med 2009; 15: 1031–1037.

20.

Hall

Reynell

Gesslein

, et al. Capillary pericytes regulate cerebral blood flow in health and disease. Nature 2014; 508: 55–60.

21.

Dalkara

Arsava

. Can restoring incomplete microcirculatory reperfusion improve stroke outcome after thrombolysis?. J Cereb Blood Flow Metab 2012; 32: 2091–2099.

22.

Dalkara

. Pericytes: a novel target to improve success of recanalization therapies. Stroke 2019; 50: 2985–2991.

23.

Enomoto

Yoshimura

Egashira

, et al. Long-term magnetic resonance angiography follow-up for recanalized vessels after mechanical thrombectomy. J Stroke Cerebrovasc Dis 2014; 23: 2834–2839.

24.

Kellert

Hametner

Rohde

, et al. Endovascular stroke therapy: Tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome. Stroke. 2013; 44: 1453–1455.

25.

Lin

Zhang

, et al. Safety and preliminary efficacy of early tirofiban treatment after alteplase in acute ischemic stroke patients. Stroke 2016; 47: 2649–2651.

26.

Hussain

Datta

Cheng

, et al. Spanning from the west to east: An updated review on endovascular treatment of intracranial atherosclerotic disease. Aging Dis 2017; 8: 196–202. Published 2017 Apr 1.